Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
Titel:
Maintenance olaparib plus bevacizumab in patients with newly diagnosed advanced high-grade ovarian cancer: Main analysis of second progression-free survival in the phase III PAOLA-1/ENGOT-ov25 trial
Auteur:
González-Martín, Antonio Desauw, Christophe Heitz, Florian Cropet, Claire Gargiulo, Piera Berger, Regina Ochi, Hiroyuki Vergote, Ignace Colombo, Nicoletta Mirza, Mansoor R. Tazi, Youssef Canzler, Ulrich Zamagni, Claudio Guerra-Alia, Eva M. Levaché, Charles B. Marmé, Frederik Bazan, Fernando de Gregorio, Nikolaus Dohollou, Nadine Fasching, Peter A. Scambia, Giovanni Rubio-Pérez, María J. Milenkova, Tsveta Costan, Cristina Pautier, Patricia Ray-Coquard, Isabelle